• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

77 岁心脏移植术后男性 SARS-CoV-2 肺炎患者成功接受抗病毒治疗

A case of SARS-CoV-2 pneumonia with successful antiviral therapy in a 77-year-old man with a heart transplant.

机构信息

Department of Internal Medicine, Bundeswehr Central Hospital Koblenz, Koblenz, Germany.

Department of Radiology, Bundeswehr Central Hospital Koblenz, Koblenz, Germany.

出版信息

Am J Transplant. 2020 Jul;20(7):1925-1929. doi: 10.1111/ajt.15932. Epub 2020 Jun 11.

DOI:10.1111/ajt.15932
PMID:32319218
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7264518/
Abstract

The SARS-CoV-2 infection can be seen as a single disease, but it also affects patients with relevant comorbidities who may have an increased risk of a severe course of infection. In this report, we present a 77-year-old patient with a heart transplant receiving relevant immunosuppressive therapy who tested positive for SARS-CoV-2 after several days of dyspnea, dry cough, and light general symptoms. Computed tomography confirmed interstitial pneumonia. The patient received antiviral therapy with hydroxychloroquine and showed no further deterioration of the clinical state. After 12 days of hospitalization, the patient was released; he was SARS-CoV-2 negative and completely asymptomatic.

摘要

SARS-CoV-2 感染可被视为一种单一疾病,但它也会影响患有相关合并症的患者,这些患者可能有感染严重的风险增加。在本报告中,我们介绍了一位 77 岁的心脏移植患者,他在出现呼吸困难、干咳和轻度全身症状数天后,检测出 SARS-CoV-2 呈阳性。计算机断层扫描证实为间质性肺炎。该患者接受了羟氯喹的抗病毒治疗,且临床状况没有进一步恶化。住院 12 天后,患者出院;他 SARS-CoV-2 检测呈阴性且完全无症状。

相似文献

1
A case of SARS-CoV-2 pneumonia with successful antiviral therapy in a 77-year-old man with a heart transplant.77 岁心脏移植术后男性 SARS-CoV-2 肺炎患者成功接受抗病毒治疗
Am J Transplant. 2020 Jul;20(7):1925-1929. doi: 10.1111/ajt.15932. Epub 2020 Jun 11.
2
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter.COVID-19 于实体器官移植受者:来自美国震中地区的初步报告。
Am J Transplant. 2020 Jul;20(7):1800-1808. doi: 10.1111/ajt.15941. Epub 2020 May 10.
3
COVID-19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine.肾移植受者 COVID-19 肺炎成功接受托珠单抗和羟氯喹治疗。
Am J Transplant. 2020 Jul;20(7):1902-1906. doi: 10.1111/ajt.15935. Epub 2020 May 13.
4
Two distinct cases with COVID-19 in kidney transplant recipients.两例肾移植受者感染 COVID-19 的病例报告。
Am J Transplant. 2020 Aug;20(8):2269-2275. doi: 10.1111/ajt.15947. Epub 2020 May 16.
5
Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19).一名2019冠状病毒病(COVID-19)肾移植患者存在危及生命的药物相互作用。
Transpl Infect Dis. 2020 Aug;22(4):e13286. doi: 10.1111/tid.13286. Epub 2020 Jul 14.
6
SARS-CoV-2 infection in two patients following recent lung transplantation.两例近期肺移植术后患者感染 SARS-CoV-2。
Am J Transplant. 2020 Oct;20(10):2928-2932. doi: 10.1111/ajt.15998. Epub 2020 Jul 22.
7
Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.COVID-19 患者伴系统性红斑狼疮,SARS-CoV-2 RNA 阳性复发后成功康复:病例报告及文献复习。
Clin Rheumatol. 2020 Sep;39(9):2803-2810. doi: 10.1007/s10067-020-05230-0. Epub 2020 Jul 28.
8
Hydroxychloroquine in Covid-19: Does the end justify the means?新冠疫情中使用羟氯喹:结果能证明手段合理吗?
Curr Res Transl Med. 2020 Aug;68(3):81-82. doi: 10.1016/j.retram.2020.04.002. Epub 2020 Apr 18.
9
Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report.肾移植受者 SARS-CoV-2 肺炎的免疫抑制治疗维持:一例报告。
Am J Transplant. 2020 Jul;20(7):1922-1924. doi: 10.1111/ajt.15920. Epub 2020 May 8.
10
Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: a report of consecutive cases from a New York City transplant center.肾移植受者、免疫抑制和 2019 年冠状病毒病:来自纽约市移植中心的连续病例报告。
Nephrol Dial Transplant. 2020 Jul 1;35(7):1250-1261. doi: 10.1093/ndt/gfaa154.

引用本文的文献

1
A methodological showcase: utilizing minimal clinical parameters for early-stage mortality risk assessment in COVID-19-positive patients.方法学展示:利用最少临床参数对新冠病毒阳性患者进行早期死亡风险评估
PeerJ Comput Sci. 2024 Apr 30;10:e2017. doi: 10.7717/peerj-cs.2017. eCollection 2024.
2
A machine learning model for predicting deterioration of COVID-19 inpatients.用于预测 COVID-19 住院患者病情恶化的机器学习模型。
Sci Rep. 2022 Feb 16;12(1):2630. doi: 10.1038/s41598-022-05822-7.
3
Recovery From COVID-19 Pneumonia in a Heart Transplant Recipient: A Case Report.心脏移植受者新冠肺炎肺炎的康复:一例报告
Infect Dis Clin Pract (Baltim Md). 2021 Nov;29(6):e401-e403. doi: 10.1097/IPC.0000000000001004. Epub 2021 Mar 8.
4
SARS-CoV-2 infection in heart transplant recipients: a systematic literature review of clinical outcomes and immunosuppression strategies.SARS-CoV-2 感染心脏移植受者:临床结局和免疫抑制策略的系统文献复习。
Heart Fail Rev. 2022 Sep;27(5):1653-1663. doi: 10.1007/s10741-021-10181-y. Epub 2021 Oct 20.
5
SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020.SARS-CoV-2 在实体器官移植受者中的研究进展:2020 年的系统综述
Transplant Proc. 2021 Oct;53(8):2421-2434. doi: 10.1016/j.transproceed.2021.08.019. Epub 2021 Aug 16.
6
Low mortality in SARS-CoV-2 infected heart transplant recipients at a single center.在单中心,SARS-CoV-2 感染的心脏移植受者死亡率低。
Clin Transplant. 2022 Jan;36(1):e14443. doi: 10.1111/ctr.14443. Epub 2021 Dec 13.
7
Cardiac transplant recipient with COVID-19 induced acute hypoxic respiratory failure: a case report.新冠病毒感染导致急性低氧性呼吸衰竭的心脏移植受者:一例报告
Eur Heart J Case Rep. 2021 Jun 26;5(6):ytab217. doi: 10.1093/ehjcr/ytab217. eCollection 2021 Jun.
8
COVID-19 in heart transplant recipients during February-August 2020: A systematic review.2020 年 2 月至 8 月间心脏移植受者中的 COVID-19:系统评价。
Clin Transplant. 2021 Sep;35(9):e14390. doi: 10.1111/ctr.14390. Epub 2021 Jun 29.
9
System for administering and monitoring hydroxychloroquine prophylaxis for COVID-19 in accordance with a national advisory: preliminary experience of a tertiary care institute in India.根据国家建议实施和监测羟氯喹预防新冠病毒病的系统:印度一家三级医疗机构的初步经验
Expert Rev Anti Infect Ther. 2021 Oct;19(10):1331-1339. doi: 10.1080/14787210.2021.1909476. Epub 2021 Apr 15.
10
Effect of immunosuppression maintenance in solid organ transplant recipients with COVID-19: Systematic review and meta-analysis.COVID-19 患者中实体器官移植受者免疫抑制维持的效果:系统评价和荟萃分析。
Transpl Infect Dis. 2021 Aug;23(4):e13595. doi: 10.1111/tid.13595. Epub 2021 Mar 18.

本文引用的文献

1
First cases of COVID-19 in heart transplantation from China.中国心脏移植中首例新冠病毒病病例。
J Heart Lung Transplant. 2020 May;39(5):496-497. doi: 10.1016/j.healun.2020.03.006. Epub 2020 Mar 17.
2
Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7).新型冠状病毒肺炎诊疗方案(试行第七版)
Chin Med J (Engl). 2020 May 5;133(9):1087-1095. doi: 10.1097/CM9.0000000000000819.
3
Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?COVID-19 于肾移植受者中的病例报告:免疫抑制是否改变临床特征?
Am J Transplant. 2020 Jul;20(7):1875-1878. doi: 10.1111/ajt.15874. Epub 2020 Apr 9.
4
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic.冠状病毒与免疫抑制患者:第三次疫情期间的实际情况
Liver Transpl. 2020 Jun;26(6):832-834. doi: 10.1002/lt.25756. Epub 2020 Apr 24.
5
COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression.COVID-19:建议检查羟氯喹预防感染和进展的效果。
J Antimicrob Chemother. 2020 Jul 1;75(7):1667-1670. doi: 10.1093/jac/dkaa114.
6
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
7
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
8
Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020.德国巴伐利亚州 2020 年 2 月快速建立新型冠状病毒 SARS-CoV-2 的实验室诊断方法。
Euro Surveill. 2020 Mar;25(9). doi: 10.2807/1560-7917.ES.2020.25.9.2000173.
9
The outbreak of COVID-19: An overview.COVID-19 疫情概述。
J Chin Med Assoc. 2020 Mar;83(3):217-220. doi: 10.1097/JCMA.0000000000000270.
10
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.